Following an amendment to the Human Medicines Regulation which comes into force on 9
th February, there will be a possibility that Serious Shortage Protocols could come into effect from this point onwards which will allow, under specific criteria for specific products, protocols with defined criteria for substitutions (
PSNC bulletin).
In the case where a substitution is made then please
sort these prescriptions into Group 1A for submission to NWSSP Prescription Pricing. These continue to follow the criteria for this group as they are not dispensed as originally prescribed.
Please ensure that for any substitution it is endorsed “
NCSO” and with the following details if they are substituted or relevant to the particular protocol (i.e. all or one of the following may be required):
- Drug Name
- Brand Name/Manufacturer/Wholesaler
- Pack size
- Form
- Strength
- Dose
- Quantity
- Price
It is also very important that the 2D barcode is not obscured.
For further general information on Serious Shortage Protocols please see
PSNC website.